This website provides information on patients with mutations in the NF2 gene, including clinical data, molecular data, management and research options.

The syndrome caused by mutations in the NF2 gene is a multisystem disorder characterized by a predisposition to develop multiple benign tumours of the nervous system, including schwannomas (particularly vestibular schwannomas), meningiomas and ependymomas, as well as non-tumour features such as cataracts.

Not all individuals with a mutation in the NF2 gene have these features.

This website was created to share and collect information about clinic, management and research projects to gather more knowledge and provide better treatment of patients with mutations in the NF2 gene.

Miriam J Smith, PhD, The University of Manchester & Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester, UK, miriam.smith@manchester.ac.uk.

D Gareth Evans, MD, The University of Manchester & Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester, UK, gareth.evans@mft.nhs.uk